EA201992557A1 - ANTITUMOR COMPOUNDS - Google Patents
ANTITUMOR COMPOUNDSInfo
- Publication number
- EA201992557A1 EA201992557A1 EA201992557A EA201992557A EA201992557A1 EA 201992557 A1 EA201992557 A1 EA 201992557A1 EA 201992557 A EA201992557 A EA 201992557A EA 201992557 A EA201992557 A EA 201992557A EA 201992557 A1 EA201992557 A1 EA 201992557A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- antitumor compounds
- antitumor
- compounds
- cancer
- compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Abstract
Соединение общей формулы I, где X, R-Rимеют разные значения, для применения в лечении рака.The compound of general formula I, where X, R-R have different meanings, for use in the treatment of cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17382497 | 2017-07-26 | ||
PCT/EP2018/060868 WO2018197663A1 (en) | 2017-04-27 | 2018-04-27 | Antitumoral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201992557A1 true EA201992557A1 (en) | 2020-02-25 |
Family
ID=59523042
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201992557A EA201992557A1 (en) | 2017-07-26 | 2018-04-27 | ANTITUMOR COMPOUNDS |
Country Status (3)
Country | Link |
---|---|
CY (1) | CY1126035T1 (en) |
EA (1) | EA201992557A1 (en) |
PT (3) | PT3615544T (en) |
-
2018
- 2018-04-27 PT PT187202551T patent/PT3615544T/en unknown
- 2018-04-27 PT PT221876642T patent/PT4101855T/en unknown
- 2018-04-27 PT PT221665714T patent/PT4047002T/en unknown
- 2018-04-27 EA EA201992557A patent/EA201992557A1/en unknown
-
2023
- 2023-06-02 CY CY20231100263T patent/CY1126035T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PT4047002T (en) | 2023-05-15 |
CY1126035T1 (en) | 2023-11-15 |
PT3615544T (en) | 2023-05-18 |
PT4101855T (en) | 2023-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201906111B (en) | Cyclic di-nucleotides compounds for the treatment of cancer | |
EA201791563A1 (en) | SUBSTITUTED NUCLEOSIDE DERIVATIVES, USEFUL AS AN AGENT AGAINST CANCER | |
PH12018502497A1 (en) | Adenosine derivatives for use in the treatment of cancer | |
GEP20217211B (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
GEP20186933B (en) | Substituted dihydroisoquinoline compounds | |
NI201800042A (en) | NEW DERIVATIVES OF PIRROLO [2,3-D] PYRIMIDINE AS DUAL INHIBITORS OF DYRK1 / CLK1 | |
EA201400178A1 (en) | BREAST CANCER TREATMENT | |
MY197626A (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
EA201790779A1 (en) | SUBSTITUTED AMINOPURIN COMPOUNDS, THEIR COMPOSITIONS AND METHODS OF TREATMENT USING SUCH CONNECTIONS | |
MY198004A (en) | Antitumoral compounds | |
PH12017501879A1 (en) | Methods for treating cancer | |
MX2018010993A (en) | Icariin and icaritin derivatives. | |
MX2018001576A (en) | Pyridines and their use in the treatment of cancer. | |
MX2019001979A (en) | PPARy AGONIST FOR TREATMENT OF BLOOD CANCERS. | |
EA201790687A1 (en) | QUINOLINCARBOXAMIDE FOR USE IN THE TREATMENT OF MULTIPLE MYELOMA | |
MX2018001575A (en) | Tricyclic compounds and their use in the treatment of cancer. | |
EA201992557A1 (en) | ANTITUMOR COMPOUNDS | |
EA201892188A1 (en) | PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS | |
GB2553684A8 (en) | Ethynylxanthines, preparation and use for cancer treatment |